PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)

被引:0
|
作者
Nakamura, A. [1 ]
Sugawara, S. [2 ]
Harada, M. [3 ]
Usui, K. [4 ]
Suzuki, T. [5 ]
Yokouchi, H. [6 ]
Maemondo, M. [7 ]
Nukiwa, T. [8 ]
Inoue, A. [1 ]
机构
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kosei Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[3] Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan
[4] Kanto Med Ctr NTT EC, Dept Resp Med, Tokyo, Japan
[5] Isawa Hosp, Dept Resp Med, Oshu, Japan
[6] Iwamizawa Rosai Hosp, Dept Resp Med, Iwamizawa, Japan
[7] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan
[8] Tohoku Univ, Dept Resp Oncol & Mol Med, Inst Dev Aging & Cancer, Sendai, Miyagi 980, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:117 / 118
页数:2
相关论文
共 50 条
  • [41] Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)
    Sugawara, S.
    Inoue, A.
    Yamazaki, K.
    Saijo, Y.
    Gomi, K.
    Ishimoto, O.
    Hommura, F.
    Maemondo, M.
    Suzuki, T.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
  • [43] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
    Igawa, Satoshi
    Otani, Sakiko
    Ryuge, Shinichiro
    Fukui, Tomoya
    Nakahara, Yoshiro
    Hiyoshi, Yasuhiro
    Ishihara, Mikiko
    Kusuhara, Seiichiro
    Harada, Shinya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Sasaki, Jiichiro
    Masuda, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 642 - 648
  • [44] Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801
    Maemondo, Makoto
    Inoue, Akira
    Sugawara, Shunichi
    Harada, Toshiyuki
    Minegishi, Yuji
    Usui, Kazuhiro
    Miwa, Koji
    Morikawa, Naoto
    Kambe, Mariko
    Ube, Kenji
    Watanabe, Kana
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Gemma, Akihiko
    Nukiwa, Toshihiro
    ONCOLOGIST, 2014, 19 (04): : 352 - 353
  • [45] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Phase II study of irinotecan and paclitaxel for patients with recurrent small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Ramalingam, S.
    Forster, J.
    Shuai, Y.
    Evans, T.
    Gooding, W. E.
    Sulecki, M.
    Belani, C. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
    Satoshi Igawa
    Sakiko Otani
    Shinichiro Ryuge
    Tomoya Fukui
    Yoshiro Nakahara
    Yasuhiro Hiyoshi
    Mikiko Ishihara
    Seiichiro Kusuhara
    Shinya Harada
    Hisashi Mitsufuji
    Masaru Kubota
    Jiichiro Sasaki
    Noriyuki Masuda
    Investigational New Drugs, 2017, 35 : 642 - 648
  • [48] Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer
    Igawa, S.
    Fukui, T.
    Shirasawa, M.
    Ozawa, T.
    Sone, H.
    Kusuhara, S.
    Nishinarita, N.
    Hiyoshi, Y.
    Kubota, M.
    Mitsufuji, H.
    Sasaki, J.
    Katagiri, M.
    Naoki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S573 - S573
  • [49] A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer
    Fukuda, Minoru
    Nakamura, Yoichi
    Kasai, Takashi
    Nagashima, Seiji
    Nakatomi, Katsumi
    Doi, Seiji
    Nakano, Hirofumi
    Takatani, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soda, Hiroshi
    Tsukamoto, Kazuhiro
    Oka, Mikio
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 741 - 745
  • [50] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive stage small-cell lung cancer
    Fukuda, M.
    Nakamura, Y.
    Kasai, T.
    Kinoshita, A.
    Fukuda, M.
    Motoshima, K.
    Iida, T.
    Nakatomi, K.
    Soda, H.
    Oka, M.
    Kohno, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)